Cailong Pharmaceuticals: Announcement on Accepting Subsidiary Guarantees
Sailong Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Sailong Pharmaceutical: Announcement on the company\'s application for credit from the bank and the actual controller providing a guarantee
Cailong Pharmaceuticals: Articles of Association (August 2024)
Sailong Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Sailong Pharmaceutical: Announcement on renewing the Company\'s 2024 Audit Institution
Sailong Pharmaceutical: Review Opinions of the 2nd Meeting of the 4th Special Meeting of Independent Directors of the Board of Directors in 2024
Sailong Pharmaceutical Group: Announcement Regarding Stock Price Volatility
Sailong Pharmaceutical Group: Announcement of the resolution of the third meeting of the fourth session of the board of directors.
Sailong Pharmaceutical Group: Company bylaws (July 2024)
Sailong Pharmaceutical Group: 002898 Cailong Pharmaceutical Investor Relations Management Information 20240514
Sailong Pharmaceutical Group: Announcement on holding the 2023 Online Results Briefing
Sailong Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Sailong Pharmaceutical: “Independent Director Work System”
Sailong Pharmaceutical: Announcement on applying for a comprehensive credit line from the bank and providing a guarantee from the company and the actual controller
Cailong Pharmaceutical: “Shareholders' Meeting Rules of Procedure”
Sailong Pharmaceutical: “External Guarantee Management System”
Sailong Pharmaceutical: Review Opinions of the 4th Special Meeting of Independent Directors of the Board of Directors at the 1st Meeting in 2024
Cailong Pharmaceuticals: 2023 Annual Audit Report
Sailong Pharmaceutical: 2023 Independent Director Debriefing Report (Pan Chuanyun)
No Data